Floatz logo

Bisoprolol Fumarate

Iatrogenic

Ukrainian Medical Stomatological AcademyUNKNOWNPhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Iatrogenic cohort.

Asset / SponsorPhaseRating
Rosuvastatin
Ukrainian Medical Stomatological Academy
Phase 4BB
Isosorbide Dinitrate
Ukrainian Medical Stomatological Academy
Phase 4BB
Aspirin
Ukrainian Medical Stomatological Academy
Phase 4BB
Pioglitazone
Ukrainian Medical Stomatological Academy
Phase 4BB
Corpril
Ukrainian Medical Stomatological Academy
Phase 4BB
Acalabrutinib
Polish Lymphoma Research Group
Phase 2B
Hydrocortisone
Mahidol University
Phase 2CCC
Valproic Acid
Sun Yat-sen University
UnknownC

Same molecule, other indications

Bisoprolol Fumarate is also rated in:

abdominal obesity-metabolic syndromeDormant
BB
Indicative · Phase 4
69 / 100
View asset →
coronary atherosclerosisDormant
BB
Indicative · Phase 4
69 / 100
View asset →
dilated cardiomyopathyDormant
B
Indicative · Phase 2/3
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →